May 5, 2020
LifeMax Appoints Michael Huang, MD, as Chief Medical Officer
Redwood City, California – (Business Wire) – May 05, 2020 – LifeMax Laboratories, Inc. (“LifeMax”), a private company ...
November 13, 2019
LifeMax Receives Orphan Drug Designation From the European...
Palo Alto, California – (Business Wire) – November 13, 2019 – LifeMax Laboratories, Inc. (“LifeMax”), a private company ...
December 3, 2018
LifeMax Appoints Kirk Johnson, Ph.D., as VP of Preclinical Development
Palo Alto, California – (Business Wire) – December 03, 2018 – LifeMax Laboratories, Inc. (“LifeMax”), a private company ...
April 14, 2020
LifeMax Receives Fast Track Designation For LM-030 for the Treatment...
Redwood City, California – (Business Wire) – April 14, 2020 – LifeMax Laboratories, Inc. (“LifeMax”), a private Company ...
July 18, 2019
LifeMax Receives Rare Pediatric Disease Designation For LM-030 ...
Palo Alto, California – (Business Wire) – July 18, 2019 – LifeMax Laboratories, Inc. (“LifeMax”), a private company focused ...
September 13, 2018
LifeMax Appoints Laman Alani, Ph.D., as VP of Product Development
Palo Alto, California – (Business Wire) – September 13, 2018 – LifeMax Laboratories, Inc. (“LifeMax”), a private company ...
March 30, 2020
LifeMax Launches AmMax Bio Following The License Of Worldwide Rights...
Redwood City, California – (Business Wire) – March 30, 2020 – LifeMax Laboratories, Inc. (“LifeMax”), a private Company ...
June 27, 2019
LifeMax Receives Orphan Drug Designation From the United States Food & ...
Palo Alto, California – (Business Wire) – June 27, 2019 – LifeMax Laboratories, Inc. (“LifeMax”), a private company focused ...
August 27, 2018
LifeMax Acquires Worldwide Right to Clinical Stage Orphan Asset
Palo Alto, California – (Business Wire) - August 27, 2018 – LifeMax Laboratories, Inc. (“LifeMax”), a private company focused ...